Advancing Vaccine Development for RSV and hMPV: Overcoming Challenges With Pre-Fusion F Protein Stability
Pharmacy Times
NOVEMBER 28, 2024
Researchers developed a method to stabilize respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) fusion (F) proteins, advancing potential vaccines for both viruses.
Let's personalize your content